Insulin Pump Therapy: Guidelines for Successful Outcomes

Release Date:  March 27, 2009
Expiration Date:  March 27, 2010

Intended Audience

This activity is intended for nurses, dietitians, pharmacists, nurse practitioners, physician assistants, mental health professionals, physicians, and other clinical practitioners involved in the management of patients with diabetes mellitus.

Program Overview

Current forms of insulin delivery used in the treatment of diabetes mellitus (DM) include syringes, pens, and insulin pumps. Insulin pump therapy, or continuous subcutaneous insulin infusion (CSII), is considered the “gold standard” in insulin delivery for most, if not all, patients with type 1 DM (T1DM). Technical advantages of insulin pump therapy include precise insulin dosing and dose flexibility. In the context of intensive diabetes management, insulin pumps can facilitate improved long-term glycemic control and reduced risk for diabetes complications as well as increased lifestyle flexibility and convenience for patients and their families. Comprehensive patient education, carbohydrate counting, and frequent self-monitoring of blood glucose (SMBG) or continuous glucose monitoring (CGM) are necessary components of successful insulin pump therapy.

Technological advances have increased the appeal of pump therapy to both patients and clinicians. Physically, insulin pumps have become sleek, discreet, ergonomic and more water resistant. Meanwhile, software revisions have yielded “smart pumps” with on-board features to support pump users in their daily diabetes management. Robust data analysis software packages allow patients and clinicians unprecedented insight into the quality of patients’ diabetes control. Furthermore, widespread insurance reimbursement for CSII has improved patients’ access to therapy. As the number of pump users and potential users expands, diabetes educators may face new challenges and opportunities to improve their patients’ lives with diabetes. This activity describes the rationale for insulin pump therapy, its potential advantages and disadvantages, and strategies regarding patient selection and education.

Program Goal

The goals of this program are:

  • To describe the principles of insulin pump therapy, review its potential advantages and disadvantages, and discuss strategies for appropriate patient selection, training, and ongoing management.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Describe the rationale for the use of insulin pump therapy and potential advantages and disadvantages of pump therapy
  • Describe the basic components of CSII
  • Identify appropriate candidates for pump therapy
  • Apply principles, regimens and strategies for starting patients on pump therapy
  • Articulate pump users' needs for ongoing support to achieve the goals of therapy

Accreditation Statements

               ANCC logo

Registered Nurses

The American Association of Diabetes Educators is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This educational program will provide 1.5 contact hours of continuing education credit.

AADE is accredited as a provider of continuing nursing education by the California Board of Registered Nursing (CEP # 10977).

CDR logo

Registered Dietitians

The American Association of Diabetes Educators, (AM001) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR) from June 1, 2009 to May 31, 2012. Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.5 continuing professional education units (CPEUs) for completion of this program. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.

ACPE logo

Registered Pharmacists

The American Association of Diabetes Educators is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program provides 1.5 contact hours (0.15 CEUs) of continuing education credit.

ACPE Universal Program Number: 069-000-09-029-H01-P
Effective Date: March 10, 2009
 

PeerPoint logo

Physicians

The Peer·Point Medical Education Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Peer·Point Medical Education Institute, LLC, designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credits.
The approval of this educational offering by AADE does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.
Release Date: March 27, 2009
Expiration Date: March 27, 2010

Faculty Information

Robert J. Sobel, MD
Assistant Professor, Endocrinology
Feinberg School of Medicine
Northwestern University
Chicago, IL

Daphne E. Smith, PharmD, CDE
Clinical Assistant Professor, Ambulatory Care/Diabetes Education
Clinical Pharmacist, Ambulatory Care
University of Illinois at Chicago
Chicago, IL

Gary Scheiner, MS, CDE
Owner/Operator
Integrated Diabetes Services
Wynnewood, PA

Anthony J. Pick, MD, CDE
Assistant Professor, Endocrinology
Feinberg School of Medicine
Northwestern University
Chicago, IL

Davida Kruger, MSN, APRN-BC, BC-ADM
Certified Nurse Practitioner
Henry Ford Health System
Detroit, MI

Jacqueline King, MS, RD, FADA, CDE
Preceptor, University of Illinois
Registered Dietitian
Private Practice
Glenview, IL

Karen Green, MSN, APN, CNP, BC-ADM, CDE
Diabetes Nurse Practitioner, Endocrinology
Dupage Medical Group
Geneva, IL

Faculty Disclosures

It is the policy of the American Association of Diabetes Educators to require that anyone who has an opportunity to affect continuing education activities content (e.g. authors, presenters and program planners) with products or services from a commercial interest with which s/he has financial relationships, discloses those financial relationship/s with commercial entities to participants.

Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:

  • Gary Scheiner, MS, CDE, received consulting fees for serving as the certified diabetes educator (CDE) advisory panel coordinator for Unomedical and for serving on the Speakers’ Bureau and as a certified insulin pump trainer and certified continuous glucose monitoring trainer for Medtronic/MiniMed. He also received honoraria for serving on the Speakers’ Bureau and as a certified insulin pump trainer for Smiths Medical.
  • Robert J. Sobel, MD, has no financial disclosures to declare.
  • Daphne E. Smith, PharmD, CDE, has no financial disclosures to declare.
  • Anthony J. Pick, MD, CDE, received honoraria for serving on the Speakers’ Bureaus for Sanofi-Aventis, Novo Nordisk, and Takeda.
  • Davida Kruger, MSN, APRN-BC, BC-ADM, receives 50% of her salary and benefits from the National Institutes of Health (NIH). She is a stock shareholder for Amylin Pharmaceuticals, Inc; Dex Com; and Patton Medical Devices. She serves on the advisory boards for Novo Nordisk; Abbott; Council for Advancement of Diabetes Research and Education Seattle Medical; Home Diagnostics, Inc; Patton Medical Devices; AgaMatrix; Eli Lilly and Company; Amylin Pharmaceuticals, Inc; and Animas Corporation. She has received honoraria from Novo Nordisk, Takeda, Amylin Pharmaceuticals, Abbott, Home Diagnostics, Eli Lilly, AgaMatrix, Animas, and Seattle Medical. In addition, she serves on the Speakers’ Bureaus for Amylin, Lilly, Novo Nordisk, and the Amylin-Lilly Alliance and receives grants/research support from the NIH (2 research studies), Eli Lilly, and Amylin Pharmaceuticals.
  • Jacqueline King, MS, RD, FADA, CDE, conducts continuing education for Bayer Corp.
  • Karen Green, MSN, APN, CNP, BC-ADM, CDE, has no financial disclosures to declare.

The approval of this educational offering by the AADE does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.

Acknowledgements

The authors wish to thank Melissa Ford for her contribution to the writing of the article.

CE Credit Information

To receive a Statement of Credit, you must:

  • Review the full content of the program; and
  • Successfully complete the post-test (70% or higher).

Note: You will have 2 opportunities to successfully complete the program.

Your statement of credit will be issued immediately upon successful completion of the test and submission of the evaluation form. 

Pricing

Member: $0
Nonmember: $35

Commercial Support

This program is organized by AADE and supported by an unrestricted educational grant from Medtronic, Inc. and LifeScan.

Technical Requirements

  • Internet Explorer 6.0 or higher, Netscape 7.2 or higher, or Firefox 1.07 or higher (turn off pop-up blocker)
  • Adobe Acrobat Reader –  download here